Bobo Wing-Yee Mok
Overview
Explore the profile of Bobo Wing-Yee Mok including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miura M, Kiuchi N, Lau S, Mok B, Ushirogawa H, Naito T, et al.
Elife
. 2025 Feb;
12.
PMID: 39996598
Influenza A virus transcribes viral mRNAs from the eight segmented viral genome when it infects. The kinetics of viral transcription, nuclear export of viral transcripts, and their potential variation between...
2.
Mok B, Kwok M, Li H, Ling L, Lai A, Yan B, et al.
Cell Biosci
. 2024 Aug;
14(1):101.
PMID: 39095802
Background: COVID-19 can cause cardiac complications and the latter are associated with poor prognosis and increased mortality. SARS-CoV-2 variants differ in their infectivity and pathogenicity, but how they affect cardiomyocytes...
3.
Chow N, Long T, Lee L, Wong I, Lee A, Tam W, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932272
Objective: This study aimed to characterize the changing landscape of circulating SARS-CoV-2 lineages in the local community of Hong Kong throughout 2022. We examined how adjustments to quarantine arrangements influenced...
4.
Xie G, Zhu L, Liu S, Li C, Diao X, Zhang Y, et al.
Sci China Life Sci
. 2023 Sep;
67(1):83-95.
PMID: 37721637
SARS-CoV-2 continues to threaten human society by generating novel variants via mutation and recombination. The high number of mutations that appeared in emerging variants not only enhanced their immune-escaping ability...
5.
Deng S, Liu Y, Tam R, Chen P, Zhang A, Mok B, et al.
Nat Commun
. 2023 Apr;
14(1):2081.
PMID: 37045873
Current available vaccines for COVID-19 are effective in reducing severe diseases and deaths caused by SARS-CoV-2 infection but less optimal in preventing infection. Next-generation vaccines which are able to induce...
6.
Zhou B, Zhou R, Tang B, Chan J, Luo M, Peng Q, et al.
Nat Commun
. 2022 Jun;
13(1):3589.
PMID: 35739114
The strikingly high transmissibility and antibody evasion of SARS-CoV-2 Omicron variants have posed great challenges to the efficacy of current vaccines and antibody immunotherapy. Here, we screen 34 BNT162b2-vaccinees and...
7.
Yuan S, Ye Z, Liang R, Tang K, Zhang A, Lu G, et al.
Science
. 2022 Jun;
377(6604):428-433.
PMID: 35737809
The in vivo pathogenicity, transmissibility, and fitness of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant are not well understood. We compared these virological attributes of this...
8.
Lian Q, Zhang K, Zhang Z, Duan F, Guo L, Luo W, et al.
Nat Commun
. 2022 Apr;
13(1):2028.
PMID: 35440562
Dysfunctional immune responses contribute critically to the progression of Coronavirus Disease-2019 (COVID-19), with macrophages as one of the main cell types involved. It is urgent to understand the interactions among...
9.
Zhou R, Wang P, Wong Y, Xu H, Lau S, Liu L, et al.
EBioMedicine
. 2021 Dec;
75:103762.
PMID: 34942445
Background: Vaccines in emergency use are efficacious against COVID-19, yet vaccine-induced prevention against nasal SARS-CoV-2 infection remains suboptimal. Methods: Since mucosal immunity is critical for nasal prevention, we investigated the...
10.
Mok B, Liu H, Deng S, Liu J, Zhang A, Lau S, et al.
Commun Biol
. 2021 Sep;
4(1):1102.
PMID: 34545191
Emerging variants of SARS-CoV-2 have been shown to rapidly replace original circulating strains in humans soon after they emerged. There is a lack of experimental evidence to explain how these...